NCT01526317View on ClinicalTrials.gov

A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Interventions
DRUG

Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)

For co-administration,Crestor 1 tablet and Glucodown 1 tablet a day for 5 day.(1 period) For separate administration, Crestor 1 tablet a day for 5 day and Glucodown 1 tablet a day for 5 day.

Trial Locations (1)

120-752

Severance Hospital, Yonsei University, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01526317 - A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers | Biotech Hunter | Biotech Hunter